肿瘤免疫疗法-话题@MedSci

#肿瘤免疫疗法#

44篇内容 | 2503人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1521486, encodeId=9d9c1521486bb, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=Nat Chem Biol：国内肿瘤免疫疗法新突破！肿瘤防御系统有望彻底被瓦解！, objectType=article, longId=152950, objectId=648d15295091, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=648d15295091, replyNumber=0, likeNumber=99, createdTime=2018-11-08, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=648d15295091, moduleTitle=Nat Chem Biol：国内肿瘤免疫疗法新突破！肿瘤防御系统有望彻底被瓦解！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=648d15295091)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521485, encodeId=4cb31521485c3, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=Cell：B7-H1/PD-1通路不仅仅是另一个“免疫检查点” 未来肿瘤免疫疗法展望，免疫正常化疗法时代已来, objectType=article, longId=150663, objectId=bd0d15066364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd0d15066364, replyNumber=0, likeNumber=97, createdTime=2018-10-11, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd0d15066364, moduleTitle=Cell：B7-H1/PD-1通路不仅仅是另一个“免疫检查点” 未来肿瘤免疫疗法展望，免疫正常化疗法时代已来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd0d15066364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521484, encodeId=761e15214840c, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=全球第6款PD-1/PD-L1肿瘤免疫疗法获批上市，竞争趋白热化！, objectType=article, longId=150497, objectId=844b15049ed6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=844b15049ed6, replyNumber=0, likeNumber=92, createdTime=2018-10-08, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=844b15049ed6, moduleTitle=全球第6款PD-1/PD-L1肿瘤免疫疗法获批上市，竞争趋白热化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=844b15049ed6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521483, encodeId=40fa152148362, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=肿瘤免疫疗法先驱获2018年诺贝尔生理学或医学奖, objectType=article, longId=150260, objectId=759d150260ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=759d150260ab, replyNumber=0, likeNumber=75, createdTime=2018-10-03, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=759d150260ab, moduleTitle=肿瘤免疫疗法先驱获2018年诺贝尔生理学或医学奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=759d150260ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521482, encodeId=5e7715214823e, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=【盘点】肿瘤免疫疗法新进展, objectType=article, longId=110343, objectId=1a6411034303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a6411034303, replyNumber=0, likeNumber=69, createdTime=2017-08-22, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a6411034303, moduleTitle=【盘点】肿瘤免疫疗法新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a6411034303)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521481, encodeId=eef8152148129, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=博雅布局肿瘤免疫疗法上游，助力CAR-T治疗进入临床, objectType=article, longId=106659, objectId=2b8c10665963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b8c10665963, replyNumber=0, likeNumber=73, createdTime=2017-07-27, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b8c10665963, moduleTitle=博雅布局肿瘤免疫疗法上游，助力CAR-T治疗进入临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b8c10665963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521480, encodeId=a88c1521480dd, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=Sci Trans Med：重磅级发现！特殊血管或能增强抗肿瘤免疫疗法的效力, objectType=article, longId=96299, objectId=65309629914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65309629914, replyNumber=0, likeNumber=73, createdTime=2017-04-19, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65309629914, moduleTitle=Sci Trans Med：重磅级发现！特殊血管或能增强抗肿瘤免疫疗法的效力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65309629914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521479, encodeId=020815214e99f, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法, objectType=article, longId=94071, objectId=2032940e105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2032940e105, replyNumber=0, likeNumber=88, createdTime=2017-03-31, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2032940e105, moduleTitle=百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2032940e105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521478, encodeId=2b3b15214e839, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=关于肿瘤免疫疗法，你应该知道的五个事实, objectType=article, longId=91006, objectId=cf5291006c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf5291006c0, replyNumber=0, likeNumber=92, createdTime=2017-03-08, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf5291006c0, moduleTitle=关于肿瘤免疫疗法，你应该知道的五个事实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf5291006c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521477, encodeId=24db15214e792, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=【盘点】“肿瘤免疫疗法”任重而道远, objectType=article, longId=88797, objectId=830488e973b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=830488e973b, replyNumber=0, likeNumber=88, createdTime=2017-02-15, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=830488e973b, moduleTitle=【盘点】“肿瘤免疫疗法”任重而道远, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=830488e973b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521476, encodeId=b20a15214e625, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, objectType=article, longId=85589, objectId=61ad855891a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61ad855891a, replyNumber=0, likeNumber=64, createdTime=2016-12-28, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61ad855891a, moduleTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61ad855891a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521475, encodeId=2ed315214e5c0, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, objectType=article, longId=85525, objectId=77d9855258f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77d9855258f, replyNumber=0, likeNumber=76, createdTime=2016-12-28, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77d9855258f, moduleTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77d9855258f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521474, encodeId=ec2a15214e42a, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=癌症治疗的新纪元----靶向治疗和肿瘤免疫疗法, objectType=article, longId=80668, objectId=3fb8806681c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fb8806681c, replyNumber=0, likeNumber=67, createdTime=2016-10-23, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fb8806681c, moduleTitle=癌症治疗的新纪元----靶向治疗和肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fb8806681c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521473, encodeId=2e6c15214e3d8, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=MIT衍生公司Immunome融资1200万美元开发新肿瘤免疫疗法, objectType=article, longId=79537, objectId=67e3e95370e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e3e95370e, replyNumber=0, likeNumber=65, createdTime=2016-10-10, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e3e95370e, moduleTitle=MIT衍生公司Immunome融资1200万美元开发新肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67e3e95370e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521472, encodeId=3dad15214e2cb, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=看好肿瘤免疫疗法领域 Celgene四处出击, objectType=article, longId=74312, objectId=11e1e4312a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e1e4312a4, replyNumber=0, likeNumber=70, createdTime=2016-08-04, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e1e4312a4, moduleTitle=看好肿瘤免疫疗法领域 Celgene四处出击, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e1e4312a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521471, encodeId=762315214e15b, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=J immunol：miRNA提高肿瘤免疫疗法效率, objectType=article, longId=73166, objectId=84f3e31660e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84f3e31660e, replyNumber=0, likeNumber=77, createdTime=2016-07-20, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84f3e31660e, moduleTitle=J immunol：miRNA提高肿瘤免疫疗法效率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84f3e31660e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521470, encodeId=dc3e15214e05b, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=肿瘤免疫疗法下一波浪潮！联合治疗, objectType=article, longId=67577, objectId=75ec6e57781, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75ec6e57781, replyNumber=0, likeNumber=67, createdTime=2016-05-07, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75ec6e57781, moduleTitle=肿瘤免疫疗法下一波浪潮！联合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75ec6e57781)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521469, encodeId=df78152146955, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=【视频】Nature动画带你看懂肿瘤免疫疗法, objectType=article, longId=66264, objectId=df6a662645f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df6a662645f, replyNumber=0, likeNumber=73, createdTime=2016-04-10, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df6a662645f, moduleTitle=【视频】Nature动画带你看懂肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df6a662645f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521468, encodeId=1ebe152146875, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=赛诺菲重金布局新一代口服小分子肿瘤免疫疗法, objectType=article, longId=54775, objectId=ed3b54e7525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed3b54e7525, replyNumber=0, likeNumber=64, createdTime=2015-08-14, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed3b54e7525, moduleTitle=赛诺菲重金布局新一代口服小分子肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed3b54e7525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521467, encodeId=67b7152146e8f, content=<a href='/topic/show?id=0e108281e8f' target=_blank style='color:#2F92EE;'>#肿瘤免疫疗法#</a>, objectTitle=肿瘤免疫疗法与表观药物durvalumab/mocetinostat联合将用于NSCLC临床试验, objectType=article, longId=54487, objectId=c95b5448e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95b5448e93, replyNumber=0, likeNumber=51, createdTime=2015-08-07, rootId=0, userName=drwjr, userId=995711357332, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95b5448e93, moduleTitle=肿瘤免疫疗法与表观药物durvalumab/mocetinostat联合将用于NSCLC临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c95b5448e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤免疫疗法

2020-05-29

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

Nat Chem Biol：国内肿瘤免疫疗法新突破！肿瘤防御系统有望彻底被瓦解！

2018-11-08

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

Cell：B7-H1/PD-1通路不仅仅是另一个“免疫检查点” 未来肿瘤免疫疗法展望，免疫正常化疗法时代已来

2018-10-11

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

全球第6款PD-1/PD-L1肿瘤免疫疗法获批上市，竞争趋白热化！

2018-10-08

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

肿瘤免疫疗法先驱获2018年诺贝尔生理学或医学奖

2018-10-03

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

【盘点】肿瘤免疫疗法新进展

2017-08-22

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

博雅布局肿瘤免疫疗法上游，助力CAR-T治疗进入临床

2017-07-27

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

Sci Trans Med：重磅级发现！特殊血管或能增强抗肿瘤免疫疗法的效力

2017-04-19

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法

2017-03-31

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

关于肿瘤免疫疗法，你应该知道的五个事实

2017-03-08

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

【盘点】“肿瘤免疫疗法”任重而道远

2017-02-15

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！

2016-12-28

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！

2016-12-28

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

癌症治疗的新纪元----靶向治疗和肿瘤免疫疗法

2016-10-23

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

MIT衍生公司Immunome融资1200万美元开发新肿瘤免疫疗法

2016-10-10

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

看好肿瘤免疫疗法领域 Celgene四处出击

2016-08-04

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

J immunol：miRNA提高肿瘤免疫疗法效率

2016-07-20

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

肿瘤免疫疗法下一波浪潮！联合治疗

2016-05-07

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

【视频】Nature动画带你看懂肿瘤免疫疗法

2016-04-10

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

赛诺菲重金布局新一代口服小分子肿瘤免疫疗法

2015-08-14

drwjr (审核中...)

前往app查看评论内容

#肿瘤免疫疗法#

肿瘤免疫疗法与表观药物durvalumab/mocetinostat联合将用于NSCLC临床试验

2015-08-07

科室
- - 订阅+
  - 更多科室
工具
服务